Marker Therapeutics Statistics
NASDAQ: MRKRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.95-0.09 (-8.65%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Marker Therapeutics by the numbers
Marker Therapeutics has a market capitalization of $15.8 million based on 16.67M shares outstanding. With trailing EPS of $-0.42, Marker Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 20.7% below its 50-day average and 33.3% below its 200-day average.
Average daily trading volume is 64.80K shares, or about $61,555 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
MRKR valuation vs. peer median
| Metric | MRKR | Peer median | Difference |
|---|---|---|---|
| Market cap | $15.84M | $16.25M | -3% |
| Avg. volume | 64.80K | 123.37K | -47% |
Peer median across 8 companies: NCEL, NEUP, ACTU, RADX, AKTX, RKTO, PTN, LPCN.
Valuation
- Market cap
- $15.84M
- EPS (TTM)
- $-0.42
- Shares outstanding
- 16.67M
Price and trading
- Previous close
- 1.04
- Open
- 1.04
- Day range
- 0.95 – 1.04
- 52-week range
- 0.84 – 2.46
- 52-week change
- -1.89%
- Beta
- —
- Volume
- 96.40K
- Average volume
- 64.80K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 12, 2025
Additional statistics
- Market Cap
- 15.84M
- Forward Pe
- -1.79
- Eps
- -0.42
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 2.46
- Week52 Low
- 0.84
- Avg Volume
- 64,795.00
- Shares Outstanding
- 16.67M
- Ma50
- 1.20
- Ma200
- 1.42
- Earnings Date
- Aug 12, 2025
- Pct From52w High
- -61.38%
- Pct From52w Low
- 13.10%